Diamond Biofund (TPE:6901) Interest Income: NT$54.93 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:6901 Diamond Biofund Inc TPE:6901
24 GF Score
Price NT$15.25
! 2 Warning Signs
View Full Analysis

What is Diamond Biofund Interest Income?

Diamond Biofund TPE:6901 +2.01% 24 Interest Income is NT$54.93 Mil as of Jun. 2026. GuruFocus rates TPE:6901 with a GF Score™ of 24/100. The stock has 2 warning signs investors should review.

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments. Diamond Biofund's interest income for the three months ended in Jun. 2026 was NT$13.69 Mil. Its interest income for the trailing twelve months (TTM) ended in Jun. 2026 was NT$54.93 Mil.

Diamond Biofund Interest Income Historical Data

* Premium members only.

The historical data trend for Diamond Biofund's Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diamond Biofund Interest Income Chart

Diamond Biofund Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Interest Income
Get a 7-Day Free Trial 0.12 0.86 16.24 15.15 53.09

Diamond Biofund Quarterly Data
Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.79 11.87 15.30 14.07 13.69
TPE:6901
24GF Score
Diamond Biofund Inc TPE:6901
Interest Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Diamond Biofund Interest Income Calculation

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments.

Interest Income for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$54.93 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Income →
What does a Interest Income of NT$54.93 Mil mean?
Diamond Biofund (TPE:6901) has a Interest Income of NT$54.93 Mil as of Jun. 2026. Interest Income is the amount a company receives on savings accounts and certificates of deposits. View historical data on Diamond Biofund and its competitors.
Is Diamond Biofund's Interest Income too high?
Diamond Biofund's current Interest Income is NT$54.93 Mil. Overall, Diamond Biofund has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Diamond Biofund's Interest Income compare to BLK and BX?
Diamond Biofund's Interest Income of NT$54.93 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Income for an Asset Management company?
A good Interest Income depends on the Asset Management industry context. However, Interest Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Income mean?
A high Interest Income can signal that a stock is expensive relative to its fundamentals. Interest Income is the amount a company receives on savings accounts and certificates of deposits. View historical data on Diamond Biofund and its competitors. Diamond Biofund's current Interest Income is NT$54.93 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diamond Biofund stock overvalued right now?
Diamond Biofund (TPE:6901) has a current Interest Income of NT$54.93 Mil. The current Interest Income is NT$54.93 Mil. Diamond Biofund's overall GF Score™ is 24/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Income calculated?
Interest Income is calculated from a company's financial statements. For Diamond Biofund (TPE:6901), the current Interest Income is NT$54.93 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Diamond Biofund Business Description

Address Zhongxiao West Road, 34th Floor, No. 66, Section 1, Zhongzheng District, Taipei, TWN, 100
Diamond Biofund Inc is a sustainable biotech venture capital that focuses on the field of biotechnology and medical investment, targeting competitive investment targets, including new drug research and development, high-end medical equipment, medical service technology, medical access, agricultural biotechnology.
24GF Score

Get the complete analysis for TPE:6901

Interest Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$15.25
Price